SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Parmenter, B A
Right arrow Articles by Benedict, R H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parmenter, B A
Right arrow Articles by Benedict, R H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test

B A Parmenter

B Weinstock-Guttman

N Garg

F Munschauer

R HB Benedict

Department of Neurology, Division of Developmental; Behavioral Neurosciences, State University of New York at Buffalo School of Medicine; Biomedical Sciences, Buffalo, NY, USA; Department of Psychology, State University of New York at Buffalo, Buffalo, NY, USA

Cognitive impairment is common in multiple sclerosis (MS), yet difficult to detect duringroutine neurologic examination. Therefore, briefscreening tests that identify patients who may benefit from a more thorough assessment or treatment are needed. We investigated the utility of the Symbol Digit Modalities Test (SDMT) as a screen for cognitive dysfunction because it can be administered and scored in about 5 minutes. One hundred MS patients and 50 healthy controls, matched on demographic variables, participated in the study. Examination procedures included the neuropsychological (NP) tests included in the Minimal Assessment of Cognitive Function in MS (MACFIMS) battery. Patients were considered impaired if they performed one and a half standard deviations below controls on two or more MACFIMS variables, excluding theSDMT. Bayesian statistics showed that a total score of 55 or lower onthe SDMT accurately categorized 72% of patients, yielding sensitivityof 0.82, specificity of 0.60, positive predictive value (PPV) of 0.71, and negative predictive value (NPV) of 0.73. These results suggest that the effectiveness of the SDMT as a screen for cognitive impairment in MS is roughly equal to that of other psychometric and questionnaire methods.

Key Words: cognition • neuropsychology • processing speed • psychological speed • screening

Multiple Sclerosis, Vol. 13, No. 1, 52-57 (2007)
DOI: 10.1177/1352458506070750


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
P. K Coyle, J. F Foley, E. J Fox, D. R Jeffery, F. E Munschauer III, and C. Tornatore
Best practice recommendations for the selection and management of patients with multiple sclerosis receiving natalizumab therapy
Multiple Sclerosis, November 1, 2009; 15(4_suppl): S26 - S36.
[Abstract] [PDF]


Home page
NeurologyHome page
A. van der Walt, J. Stankovich, M. Bahlo, B. V. Taylor, I.A.F. van der Mei, S. J. Foote, T. J. Kilpatrick, J. P. Rubio, and H. Butzkueven
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy
Neurology, September 29, 2009; 73(13): 1018 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M Ukkonen, T Vahvelainen, P Hamalainen, P Dastidar, and I Elovaara
Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study
Multiple Sclerosis, September 1, 2009; 15(9): 1055 - 1061.
[Abstract] [PDF]


Home page
NeurologyHome page
R. H.B. Benedict and F. Fazekas
Benign or not benign MS: A role for routine neuropsychological assessment?
Neurology, August 18, 2009; 73(7): 494 - 495.
[Full Text] [PDF]


Home page
Mult SclerHome page
S. Morrow, B Weinstock-Guttman, F. Munschauer, D Hojnacki, and R. Benedict
Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis
Multiple Sclerosis, August 1, 2009; 15(8): 998 - 1005.
[Abstract] [PDF]


Home page
Mult SclerHome page
G Arrondo, M Alegre, J Sepulcre, J Iriarte, J Artieda, and P Villoslada
Abnormalities in brain synchronization are correlated with cognitive impairment in multiple sclerosis
Multiple Sclerosis, April 1, 2009; 15(4): 509 - 516.
[Abstract] [PDF]


Home page
Mult SclerHome page
F Patti
Cognitive impairment in multiple sclerosis
Multiple Sclerosis, January 1, 2009; 15(1): 2 - 8.
[Abstract] [PDF]


Home page
Mult SclerHome page
B Brochet, M. Deloire, M Bonnet, E Salort-Campana, J. Ouallet, K. Petry, and V Dousset
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study
Multiple Sclerosis, November 1, 2008; 14(9): 1242 - 1249.
[Abstract] [PDF]


Home page
Mult SclerHome page
J Toledo, J Sepulcre, A Salinas-Alaman, A Garcia-Layana, M Murie-Fernandez, B Bejarano, and P Villoslada
Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis
Multiple Sclerosis, August 1, 2008; 14(7): 906 - 912.
[Abstract] [PDF]


Home page
NeurologyHome page
O. Ghaffar and A. Feinstein
Multiple sclerosis and cannabis: A cognitive and psychiatric study
Neurology, July 15, 2008; 71(3): 164 - 169.
[Abstract] [Full Text] [PDF]



Advertisement